Nika Pharmaceuticals Inc (NIKA) Price & Analysis

5 Followers

NIKA Stock Chart & Stats

$0.77

$0.00(0.00%)

At close: Jun 30 4:00 PM EDT

$0.77

$0.00(0.00%)

Day’s Range― - ―

52-Week Range$0.20 - $0.96

Previous CloseN/A

Volume50.00

Average Volume (3M)1.08K

Market Cap

$222.61M

Enterprise Value$534.55M

Total Cash (Recent Filing)$1.53K

Total Debt (Recent Filing)$0.00

Price to Earnings (P/E)―

Beta-1.06

Next EarningsN/A

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)0.00

Shares Outstanding1,048,549,200

10 Day Avg. Volume10

30 Day Avg. Volume1,076

Financial Highlights & Ratios

PEG Ratio0.00

Price to Book (P/B)-1.34K

Price to Sales (P/S)0.00

P/FCF Ratio-5.00K

Enterprise Value/Market Cap2.40

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/Ebitda-6.96K

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

NIKA FAQ

What was Nika Pharmaceuticals Inc’s price range in the past 12 months?

Nika Pharmaceuticals Inc lowest stock price was $0.20 and its highest was $0.96 in the past 12 months.

What is Nika Pharmaceuticals Inc’s market cap?

Nika Pharmaceuticals Inc’s market cap is $222.61M.

When is Nika Pharmaceuticals Inc’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

How were Nika Pharmaceuticals Inc’s earnings last quarter?

Currently, no data Available

Is Nika Pharmaceuticals Inc overvalued?

According to Wall Street analysts Nika Pharmaceuticals Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Nika Pharmaceuticals Inc pay dividends?

Nika Pharmaceuticals Inc does not currently pay dividends.

What is Nika Pharmaceuticals Inc’s EPS estimate?

Nika Pharmaceuticals Inc’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Nika Pharmaceuticals Inc have?

Nika Pharmaceuticals Inc has 1,048,549,200 shares outstanding.

What happened to Nika Pharmaceuticals Inc’s price movement after its last earnings report?

Currently, no data Available

Which hedge fund is a major shareholder of Nika Pharmaceuticals Inc?

Currently, no hedge funds are holding shares in NIKA

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Nika Pharmaceuticals Inc

Nika Pharmaceuticals Inc., a pharmaceutical enterprise headquartered in Henderson, Nevada, focuses on the creation of medications to address a broad spectrum of health conditions. Its research and development efforts target serious diseases including HIV/AIDS, hepatitis B and C, rheumatoid arthritis, cancer, and diabetes. The company's product line features antiviral treatments and nutritional supplements, notably providing a specialized thymus nuclear glycoprotein for the management of HIV. Originally established in 2000, the organization was previously known as Centennial Growth Equities Inc. before adopting its current name, Nika Pharmaceuticals, Inc., in May 2022.